Cytomegalovirus disease following liver transplantation: an analysis of prophylaxis strategies (Q44512615)

3 December 2017

title

Cytomegalovirus disease following liver transplantation: an analysis of prophylaxis strategies (English)

1 reference

3 December 2017

0 references

liver transplantation

1 reference

Singhal S

1

1 reference

3 December 2017

Khan OA

series ordinal

2

1 reference

3 December 2017

Bramble RA

series ordinal

3

1 reference

3 December 2017

Mutimer DJ

series ordinal

4

1 reference

3 December 2017

publication date

1 August 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

47

1 reference

3 December 2017

issue

2

1 reference

3 December 2017

page(s)

104-109

1 reference

Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900018-5

7 January 2021

Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900018-5

7 January 2021

Cytomegalovirus disease is associated with increased cost and hospital length of stay among orthotopic liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900018-5

7 January 2021

Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900018-5

7 January 2021

A Multivariate Analysis of Risk Factors for Cytomegalovirus Infection in Liver-Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900018-5

7 January 2021

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900018-5

7 January 2021

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900018-5

7 January 2021

Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900018-5

7 January 2021

Economic aspects of cervical cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900018-5

7 January 2021

Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900018-5

7 January 2021

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900018-5

7 January 2021

10.1016/S0163-4453(03)00018-5

Identifiers

DOI

1 reference

3 December 2017

1 reference